Breaking AI & Tech News Analyzed

Lead: Trust Cracks Over a £330‑Million NHS DealCritics say Palantir's defence‑linked ethos clashes with the health sector, prompting the UK government to reconsider a six‑year, £400 million contract that gives the firm extensive access to patient data.Erosion of Trust in Palantir’s NHS ContractThe partnership began in March 2020 with a symbolic £1‑pound NHS contract that expanded into a £330‑million Federated Data Platform (FDP) programme. Recent revelations – including a 22‑point manifesto calling for universal military service and AI weapons – have intensified scrutiny from the Good Law Project and other watchdogs.Palantir’s X post sparked renewed debate about its suitability as a health‑data steward.Legal pressure forced NHS England to release a partially redacted version of the FDP contract.Officials are openly discussing a 2027 break point for the agreement.Financial Stakes and Contract ScaleThe original £1‑pound contract grew into a six‑year relationship valued at nearly £400 million ($546 m). The flagship FDP programme alone is priced at £330‑million ($450 m) and underpins data analytics across at least ten UK government departments.Contract duration: 2020‑2026, with potential extension discussions for 2027.Key figures: £330‑million FDP, £400‑million total NHS spend.Governance Concerns and Political BacklashCritics argue that the shared architecture between Palantir’s defence‑focused Gotham platform and the civilian‑oriented Foundry system creates a “governance problem” that has not been fully addressed. Duncan McCann of the Good Law Project warns that a defence contractor’s values differ fundamentally from those of a public health service.Academic Eerke Boiten highlights the difficulty of verifying compliance, noting that similar trust gaps exist with other US tech firms operating in the NHS.Key concerns include:Unlimited employee access to patient data, as reported by the Financial Times.Opaque pseudonymisation methods – roughly 100 pages of the contract remain withheld.Potential data aggregation across multiple government departments, despite Palantir’s claim that each engagement is “walled off”.Future Outlook for Palantir’s NHS PartnershipAnalysts suggest that the NHS may either renegotiate the FDP terms, seek alternative analytics platforms, or terminate the contract by 2027 if public confidence does not improve. Transparency measures such as publishing the full Data Protection Impact Assessment (DPIA) could mitigate some concerns, but the underlying tension between defence‑origin values and public‑health responsibilities is likely to persist.

The Lead: A Breach of Trust in Public Health DataMPs have issued a stark warning regarding the NHS's decision to grant Palantir access to identifiable patient data, deeming the move 'dangerous' and likely to erode public confidence in data privacy standards. The controversy centers on the company's ability to view raw, non-anonymized health records before they are processed, a practice that contradicts standard security protocols.The Controversy: Access Before PseudonymizationThe core technical issue lies in the mechanism of access. Unlike standard protocols, NHS England has permitted contractors to view raw, identifiable patient records before they are anonymized. This bypasses a critical security layer, raising alarms about the potential for misuse or accidental exposure. The Federated Data Platform (FDP) was designed to integrate scattered datasets, but allowing 'unlimited access' to non-NHSE staff has triggered a significant security review.The Financial and Political StakesThe deal is valued at £330m, but the political cost is mounting. Rachael Maskell and Martin Wrigley have publicly condemned the project, while polling indicates that 40% of the UK public distrusts Palantir with sensitive health information, and two-thirds are generally concerned about the company's expanding public sector role. The company's history—supporting ICE immigration enforcement and military operations—clashes with the public's expectation of a healthcare provider.The Expanding Role of Private Tech in Public HealthThis incident is part of a broader pattern. Palantir is simultaneously negotiating with the Metropolitan Police for AI intelligence analysis. The 'cavalier attitude' cited by MPs suggests a systemic failure in 'security by design.' The Patients Association and campaign groups like Foxglove argue that patients never consented to having their data accessed by a company with a record in targeting people, not caring for them.Future Outlook: Heightened Scrutiny and Regulatory RiskGiven the intense scrutiny from both backbench MPs and the public, the project faces an uncertain future. The government will likely face increasing pressure to either halt the access to identifiable data or implement significantly stricter, auditable safeguards to restore trust. The risk of a public backlash could force a re-evaluation of how private contractors are integrated into critical national infrastructure.

UK lawmakers have urged the government to reconsider its £330m contract with Palantir, a technology company known for its work with Donald Trump's ICE immigration agency and the Israeli military. The contract is for the NHS federated data platform (FDP), which has sparked concerns over data privacy and the company's ties to Peter Thiel, a Trump-supporting tech billionaire.MPs, including Luke Taylor and Samantha Niblett, have described the deal as 'shameful' and 'dreadful', questioning whether Palantir can be trusted with the health records of tens of millions of British citizens. The government has confirmed it will review the contract in spring 2027, when a break clause is due.Despite £210m already being spent on the contract, the government has faced rising pressure from doctors, MPs, and the public to reconsider its deal with Palantir. The company has countered that its software has helped deliver 110,000 additional operations and reduced discharge delays.The FDP has been one of the most controversial contracts in the UK public sector, with internal documents revealing health bosses' concerns over 'negative sentiment' about the system. The government has said 137 NHS trusts have signed up to use the Palantir-powered system, but there are concerns that usage is 'shallow'.

Health‑service workers have voiced strong unease after it emerged that engineers from the controversial US tech firm Palantir were issued NHS.net email accounts. Those accounts unlock a directory containing contact details for as many as 1.5 million NHS staff members, as well as access to SharePoint file‑sharing and Microsoft Teams groups used by the service. Palantir’s engineers are supporting the rollout of the Federated Data Platform (FDP), a £300 million contract awarded in 2023 to link patient records across disparate NHS systems. The government touts FDP as a cornerstone of its plan to "reinvent the NHS" by moving from analogue to digital, promising faster diagnoses, better appointment allocation and more personalised treatment. While the use of NHS email accounts by external suppliers is not unprecedented, Palantir’s reputation for AI‑driven surveillance and military‑grade technology has amplified staff, patient and human‑rights concerns. Rory Gibson, a resident doctor, warned that his personal contact details should not be accessible to a company that also works on drone‑strike systems. The Guardian has identified at least six Palantir engineers who have been given NHS.net credentials. In response, a Palantir spokesperson argued that such access is "normal practice for government suppliers" and cited official guidance that government systems are more secure than external alternatives. Palantir claims its software has already yielded measurable benefits: 110,000 additional operations, a 15.3% reduction in discharge delays and a 6.8% rise in cancer diagnoses within 28 days of referral. The company stresses that it merely provides software, with data usage remaining under NHS control and subject to strict contractual confidentiality. David Rowland, director of the Centre for Health and the Public Interest, acknowledged that granting NHS email addresses may not breach rules but highlighted the "deep ethical concerns" that Palantir’s profit‑driven model clashes with NHS values. He called for a comprehensive review of which private firms receive public‑sector funding. Some NHS staff reported being placed in virtual Teams meetings with Palantir personnel who joined using NHS credentials, without any disclosure of their employer – a practice that further eroded trust. Under the NHSmail access policy, "independent sector organisations" delivering health and social‑care services nationally may use NHSmail. An unrestricted NHS.net account can reveal staff roles, locations, workplace details and even grant access to commercial "Blue Light" discounts. Palantir’s technology is already deployed by UK police forces and the Ministry of Defence, prompting critics to warn that its "drag‑and‑drop" interoperability could facilitate state overreach, including a potential British analogue of the US Immigration and Customs Enforcement agency. The firm’s founders include US businessman and former Trump supporter Peter Thiel and CEO Alex Karp, both known for advocating aggressive surveillance tools. Its UK arm is led by Louis Mosley, grandson of historic British fascist leader Oswald Mosley. An NHS spokesperson reiterated that all suppliers, including Palantir, operate strictly under NHS instruction, with data access governed by robust contractual confidentiality obligations.

Palantir’s claim that opposition to its NHS contract is driven by ideology was rebuked by Chi Onwurah, the Labour MP who chairs Parliament’s science, innovation and technology select committee. Onwurah said it is appropriate for ministers to explore a break‑clause option in the deal, underscoring the seriousness of the concerns raised. Louis Mosley, Palantir’s UK executive vice‑chair, had urged the government not to succumb to “ideologically motivated campaigners” as officials weighed a way out of a £330 million contract to deliver the Federated Data Platform (FDP) for NHS England. Ministers have now asked for advice on triggering the contract’s break clause amid growing scrutiny of Palantir’s expanding role in the public sector. The FDP is an AI‑enabled platform designed to integrate disparate health information across the NHS. Palantir already holds contracts with the Ministry of Defence, several police forces and the UK’s financial watchdog, the FCA. Onwurah’s cross‑party committee is set to publish its report in the coming weeks, covering the digital reorganisation of government services and the role of AI after a series of hearings that included experts, NHS leaders and representatives from companies such as Palantir. She identified three core issues: the manner in which the contract was awarded, the handling of patient data and the resulting trust deficit within the NHS, and the involvement of Peter Mandelson through his firm Global Counsel. “These are not fringe ideological concerns,” Onwurah told the Guardian. “They relate to contract transparency, vendor lock‑in, value for money and data security – matters that should concern everyone pushing the NHS towards digital transformation.” She added that the NHS’s post‑COVID fatigue and austerity‑driven burnout make any additional trust‑related resentment a significant barrier to progress. Onwurah noted that Palantir secured the contract after providing services to the NHS at a nominal cost – a tactic often used by large tech firms to position themselves as the most attractive government supplier. “It is right for the government to explore all options, including breaking the contract, given ongoing concerns about FDP uptake while Palantir remains at the helm,” she said. Liberal Democrat MP Martin Wrigley, also on the committee, urged the government to commission a new consortium of UK‑based tech experts to build a home‑grown NHS platform. During a previous committee appearance, Mosley accused British doctors of placing “ideology over patient interest” after they challenged the data‑processing contract. Speaking to the Times, Mosley warned that removing Palantir could jeopardise patient care and stall solutions to the NHS’s biggest challenges, arguing that the campaign against the firm would do more harm than good.

Palantir’s senior UK representative has warned ministers against yielding to ideologically motivated campaigners as they explore the possibility of terminating a £330 million NHS contract for the company’s Federated Data Platform (FDP).The FDP, an AI‑enabled system intended to unify patient information across the health service, is part of a broader portfolio that includes contracts with the Ministry of Defence, several police forces and the UK’s financial regulator.Louis Mosley, executive vice‑chair of Palantir UK, told The Times that abandoning the deal would jeopardise patient care and hinder progress on the NHS’s most pressing challenges. He highlighted that the platform is projected to generate £150 million in benefits by the end of the decade, delivering a £5 return for every pound spent.According to the Financial Times, senior officials have begun informal discussions about activating a break clause that would allow the FDP’s operation to be transferred to an alternative provider once the system becomes fully operational next year.Palantir, a US‑based data‑analytics firm with ties to the Israeli and US militaries and former U.S. Immigration and Customs Enforcement contracts, has faced sustained opposition from the British Medical Association, which has long criticised the use of its technology in patient‑care settings.Health officials acknowledge the reputational risk, noting that the controversy now extends beyond traditional Labour‑left and Green Party critics. A Department of Health and Social Care spokesperson emphasised that the FDP is designed to improve care coordination, accelerate cancer diagnoses and increase treatment capacity, while maintaining strict data‑security safeguards.Health Secretary Wes Streeting, speaking on the Guardian Politics Weekly podcast, recognised public unease about Palantir’s political affiliations, referencing founder Peter Thiel’s right‑wing connections. He reassured listeners that Palantir does not have direct access to patient data, stating, "The platform is operated by us; Palantir never sees the data."Adoption of Palantir’s technology within the NHS has risen from 118 to 151 organisations since June, though it remains short of the government’s target of 240 organisations by year‑end. Labour backbencher Clive Lewis noted that the issue is becoming a visible concern for voters, reflecting broader anxieties about AI and foreign‑owned infrastructure in critical public services.